-
1
-
-
84896502095
-
Synthesıs and characterızatıon of canıne parvovırus (CPV) VP2 W-7L-20 synthetıc peptıde for synthetıc vaccıne
-
Derman S, Kizilbey K, Mansuroglu B, Mustafaeva Z. Synthesıs and characterızatıon of canıne parvovırus (CPV) VP2 W-7L-20 synthetıc peptıde for synthetıc vaccıne. Fresenıus Envıronmental Bull. 2014;23(2 A):558-66.
-
(2014)
Fresenıus Envıronmental Bull
, vol.23
, Issue.2
, pp. 558-566
-
-
Derman, S.1
Kizilbey, K.2
Mansuroglu, B.3
Mustafaeva, Z.4
-
2
-
-
13444274355
-
Canine parvoviral enteritis: A review of diagnosis, management, and prevention
-
Prittie J. Canine parvoviral enteritis: a review of diagnosis, management, and prevention. J Vet Emerg Crit Care. 2004;14(3):167-76.
-
(2004)
J Vet Emerg Crit Care
, vol.14
, Issue.3
, pp. 167-176
-
-
Prittie, J.1
-
3
-
-
0026528538
-
Recombinant vaccine for canine parvovirus in dogs
-
de Turiso JL, Cortes E, Martinez C, de Ybanez RR, Simarro I, Vela C, et al. Recombinant vaccine for canine parvovirus in dogs. J Virol. 1992;66(5):2748-53.
-
(1992)
J Virol
, vol.66
, Issue.5
, pp. 2748-2753
-
-
de Turiso, J.L.1
Cortes, E.2
Martinez, C.3
de Ybanez, R.R.4
Simarro, I.5
Vela, C.6
-
4
-
-
0029847222
-
Detection of canine parvovirus antigens with antibodies to synthetic peptides
-
Vihinen-Ranta M, Lindfors E, Heiska L, Veijalainen P, Vuento M. Detection of canine parvovirus antigens with antibodies to synthetic peptides. Arch Virol. 1996;141(9):1741-8.
-
(1996)
Arch Virol
, vol.141
, Issue.9
, pp. 1741-1748
-
-
Vihinen-Ranta, M.1
Lindfors, E.2
Heiska, L.3
Veijalainen, P.4
Vuento, M.5
-
5
-
-
13444271030
-
Effectiveness of fluids and antibiotics as supportive therapy of canine parvovirus-2 enteritis in puppies
-
Kariuki NM, Nyaga P, Buoro I, Gathumbi P. Effectiveness of fluids and antibiotics as supportive therapy of canine parvovirus-2 enteritis in puppies. Bull Anim Health Prod Afr. 1990;38:379-89.
-
(1990)
Bull Anim Health Prod Afr
, vol.38
, pp. 379-389
-
-
Kariuki, N.M.1
Nyaga, P.2
Buoro, I.3
Gathumbi, P.4
-
6
-
-
0028856089
-
Peptide vaccine against canine parvovirus: Identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence
-
Casal JI, Langeveld J, Cortes E, Schaaper W, van Dijk E, Vela C, et al. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J Virol. 1995;69(11):7274-7.
-
(1995)
J Virol
, vol.69
, Issue.11
, pp. 7274-7277
-
-
Casal, J.I.1
Langeveld, J.2
Cortes, E.3
Schaaper, W.4
van Dijk, E.5
Vela, C.6
-
7
-
-
0028271128
-
First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs
-
Langeveld J, Casal JI, Osterhaus A, Cortes E, De Swart R, Vela C, et al. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol. 1994;68(7):4506-13.
-
(1994)
J Virol
, vol.68
, Issue.7
, pp. 4506-4513
-
-
Langeveld, J.1
Casal, J.I.2
Osterhaus, A.3
Cortes, E.4
de Swart, R.5
Vela, C.6
-
9
-
-
0035925680
-
Characterisation of a protective linear B cell epitope against feline parvoviruses
-
Langeveld JP, Martinez-Torrecuadrada J, Boshuizen RS, Meloen RH, Casal JI. Characterisation of a protective linear B cell epitope against feline parvoviruses. Vaccine. 2001;19(17):2352-60.
-
(2001)
Vaccine
, vol.19
, Issue.17
, pp. 2352-2360
-
-
Langeveld, J.P.1
Martinez-Torrecuadrada, J.2
Boshuizen, R.S.3
Meloen, R.H.4
Casal, J.I.5
-
10
-
-
14544272789
-
Microencapsulation peptide and protein drugs delivery system
-
Dai C, Wang B, Zhao H. Microencapsulation peptide and protein drugs delivery system. Colloids Surf B Biointerfaces. 2005;41(2):117-20.
-
(2005)
Colloids Surf B Biointerfaces
, vol.41
, Issue.2
, pp. 117-120
-
-
Dai, C.1
Wang, B.2
Zhao, H.3
-
11
-
-
84876944573
-
A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge
-
Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S. A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge. PLoS One. 2013;8(4), e61885.
-
(2013)
PLoS One
, vol.8
, Issue.4
-
-
Manish, M.1
Rahi, A.2
Kaur, M.3
Bhatnagar, R.4
Singh, S.5
-
13
-
-
84871938743
-
Carrier molecules for use in veterinary vaccines
-
Gerdts V, Mutwiri G, Richards J, Hurk SDL-V, Potter AA. Carrier molecules for use in veterinary vaccines. Vaccine. 2013;31(4):596-602.
-
(2013)
Vaccine
, vol.31
, Issue.4
, pp. 596-602
-
-
Gerdts, V.1
Mutwiri, G.2
Richards, J.3
Hurk, S.D.L.-V.4
Potter, A.A.5
-
15
-
-
77949742766
-
Microencapsulation of vaccine antigens and adjuvants for mucosal targeting
-
Rajapaksa TE, Lo DD. Microencapsulation of vaccine antigens and adjuvants for mucosal targeting. Curr Immunol Rev. 2010;6(1):29-37.
-
(2010)
Curr Immunol Rev
, vol.6
, Issue.1
, pp. 29-37
-
-
Rajapaksa, T.E.1
Lo, D.D.2
-
16
-
-
33751253462
-
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
-
des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1-27.
-
(2006)
J Control Release
, vol.116
, Issue.1
, pp. 1-27
-
-
des Rieux, A.1
Fievez, V.2
Garinot, M.3
Schneider, Y.-J.4
Préat, V.5
-
17
-
-
11844263890
-
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery
-
Chong CS, Cao M, Wong WW, Fischer KP, Addison WR, Kwon GS, et al. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release. 2005;102(1):85-99.
-
(2005)
J Control Release
, vol.102
, Issue.1
, pp. 85-99
-
-
Chong, C.S.1
Cao, M.2
Wong, W.W.3
Fischer, K.P.4
Addison, W.R.5
Kwon, G.S.6
-
18
-
-
33646139149
-
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally
-
Jaganathan K, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine. 2006;24(19):4201-11.
-
(2006)
Vaccine
, vol.24
, Issue.19
, pp. 4201-4211
-
-
Jaganathan, K.1
Vyas, S.P.2
-
19
-
-
84864410996
-
Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide
-
Taha MA, Singh SR, Dennis VA. Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide. Nanotechnology. 2012;23(32):325101.
-
(2012)
Nanotechnology
, vol.23
, Issue.32
, pp. 325101
-
-
Taha, M.A.1
Singh, S.R.2
Dennis, V.A.3
-
20
-
-
84888343277
-
Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma
-
Xiao X, Zeng X, Zhang X, Ma L, Liu X, Yu H, et al. Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma. Int J Nanomedicine. 2013;8:4553.
-
(2013)
Int J Nanomedicine
, vol.8
, pp. 4553
-
-
Xiao, X.1
Zeng, X.2
Zhang, X.3
Ma, L.4
Liu, X.5
Yu, H.6
-
21
-
-
84866747868
-
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
-
Ma W, Chen M, Kaushal S, McElroy M, Zhang Y, Ozkan C, et al. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. Int J Nanomedicine. 2012;7:1475.
-
(2012)
Int J Nanomedicine
, vol.7
, pp. 1475
-
-
Ma, W.1
Chen, M.2
Kaushal, S.3
McElroy, M.4
Zhang, Y.5
Ozkan, C.6
-
22
-
-
34548863653
-
Lectin-conjugated PLGA nanoparticles loaded with thymopentin:< i > Ex vivo bioadhesion and < i > in vivo biodistribution
-
Yin Y, Chen D, Qiao M, Wei X, Hu H. Lectin-conjugated PLGA nanoparticles loaded with thymopentin:< i > Ex vivo bioadhesion and < i > in vivo biodistribution. J Control Release. 2007;123(1):27-38.
-
(2007)
J Control Release
, vol.123
, Issue.1
, pp. 27-38
-
-
Yin, Y.1
Chen, D.2
Qiao, M.3
Wei, X.4
Hu, H.5
-
23
-
-
84892817368
-
PH-and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization
-
Topuzogullari M, Bulmus V, Dalgakiran E, Dincer S. pH-and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization. Polymer. 2014;55(2):525-34.
-
(2014)
Polymer
, vol.55
, Issue.2
, pp. 525-534
-
-
Topuzogullari, M.1
Bulmus, V.2
Dalgakiran, E.3
Dincer, S.4
-
24
-
-
84858843984
-
Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid
-
Keum C-G, Noh Y-W, Baek J-S, Lim J-H, Hwang C-J, Na Y-G, et al. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid. Int J Nanomedicine. 2011;6:2225.
-
(2011)
Int J Nanomedicine
, vol.6
, pp. 2225
-
-
Keum, C.-G.1
Noh, Y.-W.2
Baek, J.-S.3
Lim, J.-H.4
Hwang, C.-J.5
Na, Y.-G.6
-
25
-
-
84905254847
-
Poly (lactic acid)-poly (ethylene glycol) nanoparticles provide sustained delivery of a < i > Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice
-
201410
-
Dixit S, Singh SR, Yilma AN, Agee II RD, Taha M, Dennis VA. Poly (lactic acid)-poly (ethylene glycol) nanoparticles provide sustained delivery of a < i > Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice. Nanomedicine: NBM. 201410(6):1311-1321.
-
Nanomedicine: NBM
, Issue.6
, pp. 1311-1321
-
-
Dixit, S.1
Singh, S.R.2
Yilma, A.N.3
Agee, R.D.4
Taha, M.5
Dennis, V.A.6
-
26
-
-
0003629391
-
-
Inc S. Chicago, Illinois, USA: SPSS Inc
-
Inc S. SPSS for Windows version 15.0. Chicago, Illinois, USA: SPSS Inc; 2006.
-
(2006)
SPSS for Windows Version 15.0
-
-
-
27
-
-
84858115907
-
Biodegradable nanoparticles as vaccine adjuvants and delivery systems: Regulation of immune responses by nanoparticle-based vaccine
-
Springer; Berlin, Germany
-
Akagi T, Baba M, Akashi M. Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine. Polymers in Nanomedicine. Springer; Berlin, Germany. 2012, pp. 31-64.
-
(2012)
Polymers in Nanomedicine
, pp. 31-64
-
-
Akagi, T.1
Baba, M.2
Akashi, M.3
-
28
-
-
84870238185
-
Biodegradation and biocompatibility of PLA and PLGA microspheres
-
Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 2012;64:72-82.
-
(2012)
Adv Drug Deliv Rev
, vol.64
, pp. 72-82
-
-
Anderson, J.M.1
Shive, M.S.2
-
29
-
-
79953163482
-
Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design
-
Li X, Sloat BR, Yanasarn N, Cui Z. Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design. Eur J Pharm Biopharm. 2011;78(1):107-16.
-
(2011)
Eur J Pharm Biopharm
, vol.78
, Issue.1
, pp. 107-116
-
-
Li, X.1
Sloat, B.R.2
Yanasarn, N.3
Cui, Z.4
-
30
-
-
16644395235
-
Delivery of tumor antigens to dendritic cells using biodegradable microspheres
-
Springer; Zurich, Switzerland
-
Waeckerle-Men Y., Gander B, Groettrup M. Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Adoptive Immunotherapy: Methods and Protocols. Springer; Zurich, Switzerland 2005. pp. 35-46
-
(2005)
Adoptive Immunotherapy: Methods and Protocols
, pp. 35-46
-
-
Waeckerle-Men, Y.1
Gander, B.2
Groettrup, M.3
-
31
-
-
75449093784
-
The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity
-
Yan F, Zhang C, Zheng Y, Mei L, Tang L, Song C, et al. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine: NBM. 2010;6(1):170-8.
-
(2010)
Nanomedicine: NBM
, vol.6
, Issue.1
, pp. 170-178
-
-
Yan, F.1
Zhang, C.2
Zheng, Y.3
Mei, L.4
Tang, L.5
Song, C.6
-
32
-
-
85019447249
-
Peptide vaccine: Progress and challenges
-
Li W, Joshi MD, Singhania S, Ramsey KH, Murthy AK. Peptide Vaccine: Progress and Challenges. Vaccine. 2014;2(3):515-36.
-
(2014)
Vaccine
, vol.2
, Issue.3
, pp. 515-536
-
-
Li, W.1
Joshi, M.D.2
Singhania, S.3
Ramsey, K.H.4
Murthy, A.K.5
-
33
-
-
33645776262
-
Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres
-
Feng L, Qi XR, Zhou XJ, Maitani Y, Cong WS, Jiang Y, et al. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release. 2006;112(1):35-42.
-
(2006)
J Control Release
, vol.112
, Issue.1
, pp. 35-42
-
-
Feng, L.1
Qi, X.R.2
Zhou, X.J.3
Maitani, Y.4
Cong, W.S.5
Jiang, Y.6
-
34
-
-
0029558085
-
Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific cytotoxic T lymphocytes and cells
-
Moore A, McGuirk P, Adams S, Jones WC, Paul MGJ, O'Hagan DT, et al. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific cytotoxic T lymphocytes and Th1 cells. Vaccine. 1995;13(18):1741-9.
-
(1995)
Vaccine
, vol.13
, Issue.18
, pp. 1741-1749
-
-
Moore, A.1
McGuirk, P.2
Adams, S.3
Jones, W.C.4
Paul, M.G.J.5
O'Hagan, D.T.6
-
35
-
-
0028876363
-
Synthetic delivery system for tuberculosis vaccines: Immunological evaluation of the < i > M. Tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles
-
Vordermeier H, Coombes A, Jenkins P, McGee J, O'Hagan D, Davis S, et al. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the < i > M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine. 1995;13(16):1576-82.
-
(1995)
Vaccine
, vol.13
, Issue.16
, pp. 1576-1582
-
-
Vordermeier, H.1
Coombes, A.2
Jenkins, P.3
McGee, J.4
O'Hagan, D.5
Davis, S.6
-
36
-
-
83655165245
-
Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier
-
Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377-97.
-
(2011)
Polymers
, vol.3
, Issue.3
, pp. 1377-1397
-
-
Makadia, H.K.1
Siegel, S.J.2
-
37
-
-
79961079794
-
Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro
-
Sneh-Edri H, Likhtenshtein D, Stepensky D. Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro. Mol Pharm. 2011;8(4):1266-75.
-
(2011)
Mol Pharm
, vol.8
, Issue.4
, pp. 1266-1275
-
-
Sneh-Edri, H.1
Likhtenshtein, D.2
Stepensky, D.3
-
38
-
-
84878430358
-
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: A desirable candidate nanovaccine
-
Fairley SJ, Singh SR, Yilma AN, Waffo AB, Subbarayan P, Dixit S, et al. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine. Int J Nanomedicine. 2013;8:2085.
-
(2013)
Int J Nanomedicine
, vol.8
, pp. 2085
-
-
Fairley, S.J.1
Singh, S.R.2
Yilma, A.N.3
Waffo, A.B.4
Subbarayan, P.5
Dixit, S.6
-
39
-
-
84881356899
-
Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunization
-
Primard C, Poecheim J, Heuking S, Sublet E, Esmaeili F, Borchard G. Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunization. Mol Pharm. 2013;10(8):2996-3004.
-
(2013)
Mol Pharm
, vol.10
, Issue.8
, pp. 2996-3004
-
-
Primard, C.1
Poecheim, J.2
Heuking, S.3
Sublet, E.4
Esmaeili, F.5
Borchard, G.6
-
40
-
-
84906087828
-
Immunoadjuvant activity of the nanoparticles' surface modified with mannan
-
Haddadi A, Hamdy S, Ghotbi Z, Samuel J, Lavasanifar A. Immunoadjuvant activity of the nanoparticles' surface modified with mannan. Nanotechnology. 2014;25(35):355101.
-
(2014)
Nanotechnology
, vol.25
, Issue.35
, pp. 355101
-
-
Haddadi, A.1
Hamdy, S.2
Ghotbi, Z.3
Samuel, J.4
Lavasanifar, A.5
-
41
-
-
0037020525
-
Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity
-
Fonseca C, Simoes S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release. 2002;83(2):273-86.
-
(2002)
J Control Release
, vol.83
, Issue.2
, pp. 273-286
-
-
Fonseca, C.1
Simoes, S.2
Gaspar, R.3
-
42
-
-
84902470064
-
Development and evaluation of paclitaxel loaded PLGA: Poloxamer blend nanoparticles for cancer chemotherapy
-
Gupta PN, Jain S, Nehate C, Alam N, Khare V, Dubey RD, et al. Development and evaluation of paclitaxel loaded PLGA: poloxamer blend nanoparticles for cancer chemotherapy. Int J Biol Macromol. 2014;69:393-399.
-
(2014)
Int J Biol Macromol
, vol.69
, pp. 393-399
-
-
Gupta, P.N.1
Jain, S.2
Nehate, C.3
Alam, N.4
Khare, V.5
Dubey, R.D.6
-
43
-
-
79955832587
-
Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells
-
Löw K, Knobloch T, Wagner S, Wiehe A, Engel A, Langer K, et al. Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells. Nanotechnology. 2011;22(24):245102.
-
(2011)
Nanotechnology
, vol.22
, Issue.24
, pp. 245102
-
-
Löw, K.1
Knobloch, T.2
Wagner, S.3
Wiehe, A.4
Engel, A.5
Langer, K.6
-
44
-
-
70350597706
-
Development of a PLGA nanoparticle drug delivery system containing imaging/hyperthermia and chemotherapy agents
-
15-17 May 2009. Miami, Florida, USA: Springer
-
Manchanda R, Nagesetti A, Fernandez-Fernandez A, McGoron A. Development of a PLGA Nanoparticle Drug Delivery System Containing Imaging/Hyperthermia and Chemotherapy Agents, 25th Southern Biomedical Engineering Conference 2009, 15-17 May 2009. Miami, Florida, USA: Springer; 2009. p. 183-4.
-
(2009)
25th Southern Biomedical Engineering Conference 2009
, pp. 183-184
-
-
Manchanda, R.1
Nagesetti, A.2
Fernandez-Fernandez, A.3
McGoron, A.4
-
45
-
-
0031877212
-
In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants
-
Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants. J Control Release. 1998;54(2):167-75.
-
(1998)
J Control Release
, vol.54
, Issue.2
, pp. 167-175
-
-
Ramchandani, M.1
Robinson, D.2
-
46
-
-
80052892141
-
Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: Effect of formulation variables
-
Soni A, Gadad A, Dandagi P, Mastiholimath V. Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: effect of formulation variables. Asian J Pharm. 2011;5(2):57.
-
(2011)
Asian J Pharm
, vol.5
, Issue.2
, pp. 57
-
-
Soni, A.1
Gadad, A.2
Dandagi, P.3
Mastiholimath, V.4
-
48
-
-
84888324246
-
Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity
-
Pawar D, Mangal S, Goswami R, Jaganathan K. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur J Pharm Biopharm. 2013;85(3):550-9.
-
(2013)
Eur J Pharm Biopharm
, vol.85
, Issue.3
, pp. 550-559
-
-
Pawar, D.1
Mangal, S.2
Goswami, R.3
Jaganathan, K.4
-
49
-
-
84870383902
-
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
-
Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012;7:5577.
-
(2012)
Int J Nanomedicine
, vol.7
, pp. 5577
-
-
Fröhlich, E.1
-
51
-
-
84894032581
-
Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type
-
Kettler K, Veltman K, van de Meent D, van Wezel A, Hendriks AJ. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem. 2014;33(3):481-92.
-
(2014)
Environ Toxicol Chem
, vol.33
, Issue.3
, pp. 481-492
-
-
Kettler, K.1
Veltman, K.2
van de Meent, D.3
van Wezel, A.4
Hendriks, A.J.5
-
53
-
-
0033653531
-
Nitric oxide and virus infection
-
Akaike T, Maeda H. Nitric oxide and virus infection. Immunology. 2000;101(3):300-8.
-
(2000)
Immunology
, vol.101
, Issue.3
, pp. 300-308
-
-
Akaike, T.1
Maeda, H.2
-
54
-
-
0028853663
-
Role of nitric oxide in parasitic infections
-
James SL. Role of nitric oxide in parasitic infections. Microbiol Rev. 1995;59(4):533-47.
-
(1995)
Microbiol Rev
, vol.59
, Issue.4
, pp. 533-547
-
-
James, S.L.1
-
55
-
-
0033669926
-
Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-α and nitric oxide from macrophages via IFN-γ induction
-
Xing Z, Zganiacz A, Santosuosso M. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-α and nitric oxide from macrophages via IFN-γ induction. J Leukoc Biol. 2000;68(6):897-902.
-
(2000)
J Leukoc Biol
, vol.68
, Issue.6
, pp. 897-902
-
-
Xing, Z.1
Zganiacz, A.2
Santosuosso, M.3
|